Semaglutide has emerged as a promising treatment for insulin resistance. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to produce more insulin and curbing glucagon production. Furthermore, semaglutide displays potential benefits beyond diabetes m

Semaglutide has gained significant attention in recent years as a medication for treating type 2 diabetes and obesity. This powerful glucagon-like peptide-1 (GLP-1) receptor agonist works by mimicking the effects of a naturally occurring hormone in the body, promoting blood sugar control . Understa